Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BCL11B |
| Upstream (Parents) |
|---|
| (<<) CDX2 → BCL11B |
| (<<) OVOL1 → BCL11B |
| (<<) KLF5 → BCL11B |
| (<<) VDR → BCL11B |
| (<<) JUN → BCL11B |
| (<<) ELF3 → BCL11B |
| (<<) GTF2IRD1 → BCL11B |
| (<<) ELF4 → BCL11B |
| (<<) TCF7 → BCL11B |
| (<<) ELF1 → BCL11B |
| Downstream (Children) |
|---|
| BCL11B → WT1 (>>) |
| BCL11B → THRA (>>) |
| BCL11B → HESX1 (>>) |
| BCL11B → PAX8 (>>) |
| BCL11B → ZNF132 (>>) |
| BCL11B → MSX1 (>>) |
| BCL11B → TADA3 (>>) |
| BCL11B → FUBP1 (>>) |
| BCL11B → SPIB (>>) |
| BCL11B → MYOG (>>) |
| BCL11B → ETS2 (>>) |
